Cytosine modifications modulate the chromatin architecture of transcriptional enhancers

Elise A. Mahé (1) , Thierry Madigou (1) , Aurélien Sérandour (2) , Maud Bizot (1) , Stéphane Avner (1) , Frédéric Chalmel (3) , Gaëlle Palierne (1) , Raphaël Métivier (1) , Gilles Salbert (1)

1 IGDR - Institut de Génétique et Développement de Rennes
2 EMBL - European Molecular Biology Laboratory [Heidelberg]
3 Irset - Institut de recherche en santé, environnement et travail

Epigenetic mechanisms are believed to play key roles in the establishment of cell-specific transcription programs. Accordingly, the modified bases 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) have been observed in DNA of genomic regulatory regions such as enhancers, and oxidation of 5mC into 5hmC by Ten-eleven translocation (TET) proteins correlates with enhancer activation. However, the functional relationship between cytosine modifications and the chromatin architecture of enhancers remains elusive. To gain insights into their function, 5mC and 5hmC levels were perturbed by inhibiting DNA methyltransferases and TETs during differentiation of mouse embryonal carcinoma cells into neural progenitors, and chromatin characteristics of enhancers bound by the pioneer transcription factors FOXA1, MEIS1, and PBX1 were interrogated. In a large fraction of the tested enhancers, inhibition of DNA methylation was associated with a significant increase in monomethylation of H3K4, a characteristic mark of enhancer priming. In addition, at some specific enhancers, 5mC oxidation by TETs facilitated chromatin opening, a process that may stabilize MEIS1 binding to these genomic regions.

Domaines: Biochimie, Biologie Moléculaire

Elise A. Mahé, Thierry Madigou, Aurélien Sérandour, Maud Bizot, Stéphane Avner, et al.. Cytosine modifications modulate the chromatin architecture of transcriptional enhancers. Genome Research, 2017, 27 (6), pp.947-958. ⟨10.1101/gr.211466.116⟩. ⟨hal-01533248⟩